$ZYBT

Zhengye Biotechnology Holding Ltd

Nasdaq · Healthcare · Pharmaceutical Preparations · Jilin

ZYBT chart

What traders are saying about $ZYBT

Latest posts

Zhengye Biotechnology Holding Ltd news

Zhengye Biotechnology Holding Ltd key financials

USD20252024
Revenue–$25.5M
Net income-$10.0M$1.6M
Diluted EPS–$0.03
Total assets (year end)$62.4M$67.6M
Cash and equivalents (year end)–$2.5M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

About Zhengye Biotechnology Holding Ltd

Ticker
ZYBT (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Jilin
Incorporated in
China
SEC CIK
1975641

Frequently asked questions

What exchange is Zhengye Biotechnology Holding Ltd listed on?

Zhengye Biotechnology Holding Ltd trades on the Nasdaq under the ticker symbol ZYBT.

What industry is Zhengye Biotechnology Holding Ltd in?

Zhengye Biotechnology Holding Ltd is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.

Where is Zhengye Biotechnology Holding Ltd headquartered?

Zhengye Biotechnology Holding Ltd's business address on file with the SEC is in Jilin.

How much revenue did Zhengye Biotechnology Holding Ltd report?

Zhengye Biotechnology Holding Ltd reported $25.5M in revenue for calendar year 2024, according to its SEC filings.